Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But ...

The past few years have fueled a long-term bull market, yet even in this wave of growth, not all stocks have enjoyed the spoils. It’s true that ...

Ark Investment Management's chief, Cathie Wood, often focuses on technology stocks, betting on their disruptive potential in ...

Between the industry's problems and Tilray's failure to perform well, investors would be better off avoiding this stock even ...

Despite this monumental achievement, the stock has been in decline for a while. CRISPR Therapeutics remains unprofitable, and Casgevy has yet to contribute much revenue. Could the company turn ...

But that doesn't mean that any stock down big is a good buy. In many cases, investors could be setting themselves for pain and losses instead. For years, investing in Tilray stock has been a way ...

Steven Cress analyzes 6 beaten down stocks to buy. Each pick has strong fundamentals according to Seeking Alpha's Quant ...

The healthcare company blamed the slowdown on a restructuring of its salesforce, but investors were quick to dump the stock, which finished the year down 37%. This is another stock to watch ...

She looks for beaten-down stocks that she believes are undervalued with catalysts for growth, which can include companies with management changes or firms that are restructuring. Potential ideas ...

Many beaten-down stocks are performing poorly for good reasons. These types of stocks are known as falling knives in the investing trade, and here are two examples best avoided: Tilray Brands ...

She looks for beaten-down stocks that she believes are undervalued with catalysts for growth, which can include companies with management changes or firms that are restructuring. Potential ideas ...

That's what happened in Canada. Perhaps if the company had a track record of solid financial performance, it might have been worth considering the stock. But that's not the case.